Kuchyne na miru


Sep 02, 2019
As well as official European projections of sharply slowing industry growth and geopolitical concerns, pharma executives face additional hazards as they plot their medium-term strategies, writes Reflector.
Aug 22, 2019
Leela Barham talks to Sir David Haslam, the outgoing Chair of UK’s National Institute for Health and Care Excellence (NICE), about the highs and lows of his six-year tenure at the organization.
Aug 08, 2019
Pharmaceutical Executive
Exploring the EU’s struggles and new efforts in promoting cell and gene drugs.
Aug 07, 2019
Pharmaceutical Executive
Efforts in motion for cross-border sharing, but barriers are many, writes Reflector.
Jul 23, 2019
Matthias Wernicke, General Manager of Merck KGaA’s Biopharma business in Russia, talks about how the country is transitioning from an emerging to a mature pharmaceutical market.
Jul 14, 2019
Pharmaceutical Executive
A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.
Jul 11, 2019
Pharmaceutical Executive
What are we to make of the simmering public and political angst, asks Reflector
Jul 09, 2019
See Li Lynn, LEO Pharma’s HR Manager, South Asia, talks about how LEO is managing the compliance challenges in Asia.
Jun 26, 2019
By Jin Zhang M.D., Ph.D
Both foreign and domestic pharmas are in a race to bring PD-1/PD-L1 inhibitors into China, writes Jin Zhang.
Jun 21, 2019
Chris Round, Head of International Operations & Global Core Franchises at Merck KGaA, Darmstadt, Germany, talks to Pharm Exec about his role in advancing the company’s “double mission."


У нашей фирмы популярный портал про направление https://uniti.ua.
lorem ipsum